FDA Approval History
This list consists of medications tracked by Drugs.com through the application and approval process at the U.S. Food and Drug Administration (FDA). Where possible, we have assembled information in chronological order to show the history of a medication. May only show partial information and does not include non-US drug approvals. For information about non-US medications, please visit the international drugs section.
Latest Drug Approvals
- Kloxxado (naloxone hydrochloride) - April 30, 2021
- Zynlonta (loncastuximab tesirine-lpyl) - April 23, 2021
- Jemperli (dostarlimab-gxly) - April 22, 2021
- Nextstellis (drospirenone and estetrol) - April 15, 2021
- Qelbree (viloxazine hydrochloride) - April 02, 2021
- Abecma (idecabtagene vicleucel) - March 26, 2021
- Roszet (ezetimibe and rosuvastatin) - March 23, 2021
- Zegalogue (dasiglucagon) - March 22, 2021
- Ponvory (ponesimod) - March 18, 2021
- Kimyrsa (oritavancin) - March 12, 2021
- Fotivda (tivozanib) - March 10, 2021
- Azstarys (dexmethylphenidate and serdexmethylphenidate) - March 02, 2021
- Nulibry (fosdenopterin) - February 26, 2021
- Pepaxto (melphalan flufenamide) - February 26, 2021
- Amondys 45 (casimersen) - February 25, 2021
- Cosela (trilaciclib) - February 12, 2021
- Evkeeza (evinacumab-dgnb) - February 11, 2021
- Breyanzi (lisocabtagene maraleucel) - February 05, 2021
- Ukoniq (umbralisib) - February 05, 2021
- Tepmetko (tepotinib) - February 03, 2021